Growth hormone-releasing activity in extracts of bronchial carcinoid and pancreatic islet tumors associated with acromegaly

L. A. Frohman, M. Szabo, M. E. Stachura, M. Berelowitz

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Data presented provide evidence for the production of a GHRF by carcinoid and pancreatic islet tumors which stimulates GH overproduction by the pituitary leading to acromegaly and to pituitary tumor formation. These features, which constitute an 'ectopic GHRF syndrome', provide an explanation for the association of pituitary tumors with carcinoid and pancreatic islet tumors of the multiple endocrine neoplasia syndrome, Type I, and indicate that consideration of an extrapituitary tumor is warranted in every patient with acromegaly. These tumors produce both GHRF and somatostatin and the ultimate clinical expression undoubtedly reflects the ratio of release of these two factors into circulation. The identity of the GHRF in various tumors remains to be established as does the relationship by hypothalamic GHRF. However, the results indicate that excess secretion of GHRF can produce not only enhanced GH secretion but can also lead to pituitary tumor formation, and, therefore, provide evidence to support the hypothesis that at least some GH-secreting pituitary tumors are caused by hypersecretion of a hypothalamic GHRF.

Original languageEnglish (US)
Title of host publicationTransactions of the Association of American Physicians
Pages77-88
Number of pages12
VolumeVol 92
StatePublished - Dec 1 1979
Externally publishedYes

Fingerprint

Acromegaly
Carcinoid Tumor
Islets of Langerhans
Growth Hormone
Pituitary Neoplasms
Neoplasms
Multiple Endocrine Neoplasia
Multiple Endocrine Neoplasia Type 1
Somatostatin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Frohman, L. A., Szabo, M., Stachura, M. E., & Berelowitz, M. (1979). Growth hormone-releasing activity in extracts of bronchial carcinoid and pancreatic islet tumors associated with acromegaly. In Transactions of the Association of American Physicians (Vol. Vol 92, pp. 77-88)

Growth hormone-releasing activity in extracts of bronchial carcinoid and pancreatic islet tumors associated with acromegaly. / Frohman, L. A.; Szabo, M.; Stachura, M. E.; Berelowitz, M.

Transactions of the Association of American Physicians. Vol. Vol 92 1979. p. 77-88.

Research output: Chapter in Book/Report/Conference proceedingChapter

Frohman, LA, Szabo, M, Stachura, ME & Berelowitz, M 1979, Growth hormone-releasing activity in extracts of bronchial carcinoid and pancreatic islet tumors associated with acromegaly. in Transactions of the Association of American Physicians. vol. Vol 92, pp. 77-88.
Frohman LA, Szabo M, Stachura ME, Berelowitz M. Growth hormone-releasing activity in extracts of bronchial carcinoid and pancreatic islet tumors associated with acromegaly. In Transactions of the Association of American Physicians. Vol. Vol 92. 1979. p. 77-88
Frohman, L. A. ; Szabo, M. ; Stachura, M. E. ; Berelowitz, M. / Growth hormone-releasing activity in extracts of bronchial carcinoid and pancreatic islet tumors associated with acromegaly. Transactions of the Association of American Physicians. Vol. Vol 92 1979. pp. 77-88
@inbook{81dc494f07f94a539191449499d5fc91,
title = "Growth hormone-releasing activity in extracts of bronchial carcinoid and pancreatic islet tumors associated with acromegaly",
abstract = "Data presented provide evidence for the production of a GHRF by carcinoid and pancreatic islet tumors which stimulates GH overproduction by the pituitary leading to acromegaly and to pituitary tumor formation. These features, which constitute an 'ectopic GHRF syndrome', provide an explanation for the association of pituitary tumors with carcinoid and pancreatic islet tumors of the multiple endocrine neoplasia syndrome, Type I, and indicate that consideration of an extrapituitary tumor is warranted in every patient with acromegaly. These tumors produce both GHRF and somatostatin and the ultimate clinical expression undoubtedly reflects the ratio of release of these two factors into circulation. The identity of the GHRF in various tumors remains to be established as does the relationship by hypothalamic GHRF. However, the results indicate that excess secretion of GHRF can produce not only enhanced GH secretion but can also lead to pituitary tumor formation, and, therefore, provide evidence to support the hypothesis that at least some GH-secreting pituitary tumors are caused by hypersecretion of a hypothalamic GHRF.",
author = "Frohman, {L. A.} and M. Szabo and Stachura, {M. E.} and M. Berelowitz",
year = "1979",
month = "12",
day = "1",
language = "English (US)",
volume = "Vol 92",
pages = "77--88",
booktitle = "Transactions of the Association of American Physicians",

}

TY - CHAP

T1 - Growth hormone-releasing activity in extracts of bronchial carcinoid and pancreatic islet tumors associated with acromegaly

AU - Frohman, L. A.

AU - Szabo, M.

AU - Stachura, M. E.

AU - Berelowitz, M.

PY - 1979/12/1

Y1 - 1979/12/1

N2 - Data presented provide evidence for the production of a GHRF by carcinoid and pancreatic islet tumors which stimulates GH overproduction by the pituitary leading to acromegaly and to pituitary tumor formation. These features, which constitute an 'ectopic GHRF syndrome', provide an explanation for the association of pituitary tumors with carcinoid and pancreatic islet tumors of the multiple endocrine neoplasia syndrome, Type I, and indicate that consideration of an extrapituitary tumor is warranted in every patient with acromegaly. These tumors produce both GHRF and somatostatin and the ultimate clinical expression undoubtedly reflects the ratio of release of these two factors into circulation. The identity of the GHRF in various tumors remains to be established as does the relationship by hypothalamic GHRF. However, the results indicate that excess secretion of GHRF can produce not only enhanced GH secretion but can also lead to pituitary tumor formation, and, therefore, provide evidence to support the hypothesis that at least some GH-secreting pituitary tumors are caused by hypersecretion of a hypothalamic GHRF.

AB - Data presented provide evidence for the production of a GHRF by carcinoid and pancreatic islet tumors which stimulates GH overproduction by the pituitary leading to acromegaly and to pituitary tumor formation. These features, which constitute an 'ectopic GHRF syndrome', provide an explanation for the association of pituitary tumors with carcinoid and pancreatic islet tumors of the multiple endocrine neoplasia syndrome, Type I, and indicate that consideration of an extrapituitary tumor is warranted in every patient with acromegaly. These tumors produce both GHRF and somatostatin and the ultimate clinical expression undoubtedly reflects the ratio of release of these two factors into circulation. The identity of the GHRF in various tumors remains to be established as does the relationship by hypothalamic GHRF. However, the results indicate that excess secretion of GHRF can produce not only enhanced GH secretion but can also lead to pituitary tumor formation, and, therefore, provide evidence to support the hypothesis that at least some GH-secreting pituitary tumors are caused by hypersecretion of a hypothalamic GHRF.

UR - http://www.scopus.com/inward/record.url?scp=0018653599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018653599&partnerID=8YFLogxK

M3 - Chapter

C2 - 232947

AN - SCOPUS:0018653599

VL - Vol 92

SP - 77

EP - 88

BT - Transactions of the Association of American Physicians

ER -